https://www.selleckchem.com/pr....oducts/gsk2334470.ht
5 [-0.7, 1.7],-1.0 [-0.1, 2.0],-0.2 [-0.8, 1.3]), and identical average VAS pain scores on postoperative days 4 and 7. These differences and all postoperative outcome measures were not statistically significant at any time point. A single 266-milligram vial of liposomal bupivacaine costs $351, and a single-shot ACB costs $893 at our institution. This randomized controlled trial shows similar postoperative pain control, functional outcomes, and opioid use between LB-PAI and a single-shot ACB in patients undergoing primary TKA. However
Like
Comment
Share
